检索

期
标题
作者
卷 92, 编号 6 (2020)
Modern view on treatment of membranous nephropathy
Bobkova I., Kamyshova E.
PDF
(Rus)
卷 90, 编号 9 (2018)
Proton pump inhibitors receiving and prognosis of patients after scheduled percutaneous coronary interventions
Komarov A., Shakhmatova O., Muraseeva V., Novikova E., Guskova E., Panchenko E.
PDF
(Rus)
卷 89, 编号 2 (2017)
Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice
Andreev D., Dicheva D., Maev I.
PDF
(Rus)
卷 86, 编号 9 (2014)
Principles of choice of an angiotensin-converting enzyme inhibitor: Specific features of perindopril
Morozova T., Gontarenko S., Kuz'mina E.
卷 85, 编号 11 (2013)
Experience with Invirase as part of triple therapy as the drug of choice in the perinatal prevention of HIV transmission in the Ulyanovsk Region
Salminskaia O.
卷 84, 编号 8 (2012)
Role of matrix metalloproteinase-9 in the pathogenesis of osteoporosis in patients with chronic obstructive pulmonary disease
Kochetkova E., Ugaĭ L., Maĭstrovskaia I., Buria K., Nevzorova V.
卷 81, 编号 7 (2009)
Significance of matrix metalloproteinases and their ihhibitors in normal subjects, solid and blood cancer patients
Gaydamaka N., Parovichnikova E., Zavalishina L., Savchenko V., Frank G., Gaidamaka N., Parovichnikova E., Zavalishina L., Savchenko V., Frank G.
卷 80, 编号 2 (2008)
Influence of long-term intake of proton pump inhibitors on gastric mucosa and neuroendocrine system of gastric secretion regulation in patients with acid-dependent diseases
Rapoport S., Khutsishvili M., Rasulov M., Trubitsina I., Raĭkhlin I.
卷 78, 编号 5 (2003)
Interaction of nonsteroid antiinflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)
Tsurko V., Preobrazhensky D., Obukhova О.
卷 93, 编号 1 (2021)
Pharmacotherapy for acute respiratory infections caused by influenza viruses: current possibilities
Zyryanov S., Butranova O., Gaidai D., Kryshen K.
PDF
(Rus)
卷 92, 编号 5 (2020)
Survival of bDMARDs in bionaive patients with rheumatoid arthritis: data from a retrospective 12-month follow-up
Aronova E., Lukina G., Glukhova S., Gridneva G., Kudryavtseva A.
PDF
(Rus)
卷 91, 编号 2 (2019)
The use of Tofacitinib in the treatment of inflammatory bowel disease
Nasonov E., Abdulganieva D., Fairushina I.
PDF
(Rus)
卷 89, 编号 2 (2017)
Possibilities of pH impedance and high-resolution manometry in managing patients with refractory gastroesophageal reflux disease
Maev I., Barkalova E., Ovsepyan M., Kucheryavyi Y., Andreev D.
PDF
(Rus)
卷 86, 编号 8 (2014)
Effect of dipeptidyl peptidase-4 inhibitors on fat metabolism in patients with type 2 diabetes mellitus
Ametov A., Gusenbekova D.
卷 85, 编号 8 (2013)
Pharmacotherapy for rheumatoid arthritis in the early 21st century: Russian and international experience
Nasonov E., Karateev D., Lukina G.
卷 83, 编号 8 (2011)
Diagnosis and treatment of gastroesophageal reflux disease
Trukhmanov A., Trukhmanov A.
卷 81, 编号 5 (2009)
Prophylaxis of cardiovascular diseases in rheumatoid arthritis
Novikova D., Popkova T., Nasonov E., Novikova D., Popkova T., Nasonov E.
卷 79, 编号 10 (2004)
ACE inhibitors in the treatment of ischemicheart disease and prevention of its complications (review)
Schekotov V.
卷 78, 编号 3 (2003)
Change in the activity of angiotensin-converting enzyme in pneumonia and chronic obstructive lung diseases
Altshuler B., Roitman A., Fedorova T., Novazhenov V., Belkov S., Gordeev M., Yarovaya G., Neshkova Y., Ustinov A.
卷 97, 编号 5 (2025): Issues of rheumatology
Advances in pharmacotherapy for immunoinflammatory rheumatic diseases in the 21st century
Nasonov E.
PDF
(Rus)
卷 95, 编号 8 (2023)
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
PDF
(Rus)
卷 92, 编号 12 (2020)
Effect of physicochemical properties on the pharmacokinetic parameters of the new representative of benzothiazinones antituberculosis drug macozinonе
Khokhlov A., Mariandyshev A., Shcherbakova V., Ozerova I., Kazaishvili Y., Igumnova O., Bolgarina A., Rudoy B.
PDF
(Rus)
卷 92, 编号 3 (2020)
The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)
Mariandyshev A., Khokhlov A., Smerdin S., Shcherbakova V., Igumnova O., Ozerova I., Bolgarina A., Nikitina N.
PDF
(Rus)
卷 90, 编号 8 (2018)
Problems of nociception in gastroesophageal reflux disease: diagnostics and treatment of irritated oesophagus
Sablin O., Ilchishina T.
PDF
(Rus)
卷 88, 编号 3 (2016)
Resistance to protease inhibitors and efficiency of antiviral therapy in patients with chronic hepatitis C
Batskikh S., Karandashova I., Neverov A., Chulanov V.
PDF
(Rus)
卷 86, 编号 8 (2014)
Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases
Samsonov A., Grechushnikov V., Andreev D., Iurenev G., Korovina T., Lezhneva I., Maev I.
卷 85, 编号 7 (2013)
Therapeutic strategy for chronic myeloid leukemia: possibilities and prospects
Turkina A., Chelysheva E.
卷 81, 编号 5 (2009)
Fozinopril in the treatment of cardiorenal syndrome in chronic cardiac failure
Tereshchenko S., Zhirov I., Tereschenko S., Zhirov I.
卷 79, 编号 11 (2004)
How to diagnose functional (non-ulcerative) dyspepsia (a review)
Маеу I., Vyuchnova Y., Lebedeva Y., Yakimova S.
卷 78, 编号 1 (2003)
ACE inhibitor quinapril in the treatment of chronic cardiac failure
Gadzhiev A.
卷 96, 编号 12 (2024): VARIO (РАЗНОЕ)
Rebamipide: thirty years of experience. A review
Bakulina N., Ponomarenko V., Bakulin I.
PDF
(Rus)
卷 95, 编号 8 (2023)
The effect of a medicinal plant preparation on the frequency of episodes of exacerbation of recurrent cystitis and metabolic parameters in patients with type 2 diabetes mellitus taking glyphlosins
Tsygankova O., Evdokimova N., Timoshchenko O., Latyntseva L.
PDF
(Rus)
卷 91, 编号 6 (2019)
Modern approaches to conservative therapy of polycystic kidney disease
Rudenko T., Bobkova I., Stavrovskaya E.
PDF
(Rus)
卷 90, 编号 7 (2018)
Diagnostics and treatment challenges of Ph-like acute lymphoblastic leukemia: a description of 3 clinical cases
ZARUBINA K., PAROVICHNIKOVA E., BASKHAEVA G., KRASILNIKOVA A., GAVRILINA O., BIDERMAN B., SUDARIKOV A., BONDARENKO S., DAVYDOVA Y., GALTSEVA I., SOKOLOV A., TROITSKAYA V., SAVCHENKO V.
PDF
(Rus)
卷 87, 编号 4 (2015)
Adherence with proton pump inhibitor therapy, by continuously taking nonsteroidal anti-inflammatory drugs
Pimanov S., Makarenko E., Dikareva E.
卷 86, 编号 3 (2014)
Eradication therapy for Helicobacter pylori infection: Review of world trends
Maev I., Kucheriavyĭ I., Andreev D., Barkalova E.
卷 85, 编号 1 (2013)
Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
Ametov A., Kamynina L.
卷 83, 编号 5 (2011)
Optimization of the control of blood pressure. What contribution can be obtained from use of combinations of fixed doses of ACE inhibitors and calcium channel blockers?
Eliseev O., Eliseev O.
卷 81, 编号 7 (2009)
Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase
Vinogradova O., Turkina A., Vorontsova A., Chelysheva E., Gusarova G., Kuznetsov S., Goryacheva S., Sokolova M., Abakumov E., Stakhina O., Domracheva E., Misyurin A., Khoroshko N., Vinogradova O., Turkina A., Vorontsova A., Chelysheva E., Gusarova G., Kuznetsov S., Goryacheva S., Sokolova M., Abakumov E., Stakhina O., Domracheva E., Misyurin A., Khoroshko N.
卷 79, 编号 10 (2004)
Erectile dysfunction in patients withischemic heart disease (review)
Gamidov S., Mazo E., Ovchinnikov R., Kurochkin E., Iremashvili V.
51 - 90 的 90 信息 << < 1 2 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语